β-Hydroxy-β-methylbutyrate: Clinical Trials

2 trials of β-Hydroxy-β-methylbutyrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 1, Unknown 1

Follow β-Hydroxy-β-methylbutyrate: new trials by email Literature Review of β-Hydroxy-β-methylbutyrate trials Research Report on β-Hydroxy-β-methylbutyrate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.
β-Hydroxy-β-methylbutyrate, 2-hydroxybenzylamine, β-Hydroxy-β-methylbutyrate and 2-hydroxybenzylamine - Muscle, Cognitive Functioning
Not applicableRecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre1202026-03-062026-05-14
Effect of Exercise With and Without HMB on Body Composition and Muscle Strength in Sickle Cell Anaemia
Resistance exercise, β-hydroxy-β-methylbutyrate, placebo - Sickle Cell Anemia
Not applicableUnknownThe University of The West Indies242013-04-302019-06-28

Conditions studied

Anemia, Sickle Cell (1)

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  The University of The West Indies (1)

Countries

Canada (1)

Top investigators

Asha V Badaloo, PhD (1)  ·  Gustavo Duque, Medical Doctor (1)  ·  Marvin E Reid, MBBS, PhD (1)